Product Name: Tropisetron hydrochloride
Synonyms: 3-TROPANYLINDOLE-3-CARBOXYLATE HYDROCHLORIDE;(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLIC ACID ESTER MONOHYDROCHLORIDE;TROPISETRON HYDROCHLORIDE 98.5-101.5%;TropisetronHcl/Mesylate;1H-Indole-3-carboxylic acid, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, hydrochloride (1:1);1H-Indole-3-carboxylic acid (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride;Novaban;SDZ-ICS 930
CAS: 105826-92-4
MF: C17H21ClN2O2
MW: 320.81
EINECS: 630-417-9
Melting point: 283-285°C
Storage temp.: 2-8°C
Description:
Tropisetron hydrochloride is a potent and selective 5HT3 receptor antagonist. It was developed by Novartis and listed in the UK in 1992 under the trade name Navoban. It is used to prevent and treat nausea and vomiting caused by radiotherapy and chemotherapy. The drug has been on the market in dozens of countries around the world. At present, its indications have been expanded to prevent and treat nausea and vomiting in children after radiotherapy and chemotherapy, and to prevent and treat postoperative nausea and vomiting in adults. The biggest feature of tropisetron hydrochloride is its definite curative effect and resistance. It has the advantages of good receptivity, low side effects and is very convenient to use; it only needs slow intravenous injection or infusion before radiotherapy and chemotherapy.
China
